FDA approves Rockwell Medical's iron replacement drug

(Reuters) - The Food and Drug Administration approved Rockwell Medical Inc's drug for treating iron loss in chronic kidney disease patients on dialysis, sending the company's shares up about 15 percent in premarket trading.

http://feedproxy.google.com/~r/reuters/healthNews/~3/WEQNdjqWC0E/story01.htm

Source: Reuters: Health - January 26, 2015 Category: Consumer Health News Tags: healthNews Source Type: news

More News: Chronic Kidney Disease | Dialysis | Food and Drug Administration (FDA) | Health | Urology & Nephrology